Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registry.
Yu Jun WongR KumarRahul KumarJ TanC H LiuVw-K HuiS S TanJia-Horng KaoGl-H WongP H ThurairajahPublished in: Journal of gastroenterology and hepatology (2022)